Daniel Kazdal

3.2k total citations · 1 hit paper
76 papers, 1.5k citations indexed

About

Daniel Kazdal is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Daniel Kazdal has authored 76 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 39 papers in Oncology and 34 papers in Cancer Research. Recurrent topics in Daniel Kazdal's work include Lung Cancer Treatments and Mutations (35 papers), Cancer Genomics and Diagnostics (34 papers) and Lung Cancer Research Studies (13 papers). Daniel Kazdal is often cited by papers focused on Lung Cancer Treatments and Mutations (35 papers), Cancer Genomics and Diagnostics (34 papers) and Lung Cancer Research Studies (13 papers). Daniel Kazdal collaborates with scholars based in Germany, Switzerland and United States. Daniel Kazdal's co-authors include Albrecht Stenzinger, Rémi Longuespée, Peter Schirmacher, Mark Kriegsmann, Petros Christopoulos, Volker Endris, Jan Budczies, Arne Warth, Torsten Müller and Jeroen Krijgsveld and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Daniel Kazdal

70 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumour mutational burden: clinical utility, challenges and emerging improvements

2024 47 citations Jan Budczies, Daniel Kazdal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Kazdal Germany	23	658	558	512	413	225	76	1.5k
Lyly Le Canada	13	465 0.7×	622 1.1×	544 1.1×	281 0.7×	60 0.3×	22	1.3k
Mary E. Edgerton United States	21	812 1.2×	1.3k 2.4×	354 0.7×	781 1.9×	334 1.5×	46	2.4k
Katharina Kriegsmann Germany	19	441 0.7×	353 0.6×	230 0.4×	100 0.2×	210 0.9×	105	1.1k
Stephanie M. McGregor United States	18	345 0.5×	490 0.9×	374 0.7×	245 0.6×	52 0.2×	52	1.3k
Waldemar Wilczak Germany	30	842 1.3×	1.1k 1.9×	826 1.6×	599 1.5×	77 0.3×	93	2.3k
Michelle R. Downes Canada	21	391 0.6×	397 0.7×	666 1.3×	286 0.7×	75 0.3×	77	1.3k
Gregory Bloom United States	18	409 0.6×	737 1.3×	337 0.7×	500 1.2×	44 0.2×	30	1.5k
Barry L. Dowell United States	23	404 0.6×	514 0.9×	805 1.6×	210 0.5×	101 0.4×	49	1.9k
Wataru Nishio Japan	21	566 0.9×	387 0.7×	1.3k 2.5×	179 0.4×	73 0.3×	91	2.0k
Jung Wook Park United States	19	652 1.0×	663 1.2×	727 1.4×	317 0.8×	31 0.1×	28	1.5k

Countries citing papers authored by Daniel Kazdal

Since Specialization

Citations

This map shows the geographic impact of Daniel Kazdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Kazdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Kazdal more than expected).

Fields of papers citing papers by Daniel Kazdal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Kazdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Kazdal. The network helps show where Daniel Kazdal may publish in the future.

Co-authorship network of co-authors of Daniel Kazdal

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Kazdal. A scholar is included among the top collaborators of Daniel Kazdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Kazdal. Daniel Kazdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kahles, André, Manuel Salto‐Tellez, Michael Vogeser, et al.. (2025). Regulation of laboratory-developed tests and in-house in vitro diagnostic medical devices in the United States and the European Union—a comparative overview. ESMO Open. 10(12). 105909–105909.

Würth, Roberto, Laura L. Michel, Verena Thewes, et al.. (2025). Biopsy‐derived organoids in personalised early breast cancer care: Challenges of tumour purity and normal cell overgrowth cap their practical utility. International Journal of Cancer. 156(11). 2200–2209.

Schmitz, Daniel, et al.. (2025). Differentiation of MD-IPMN from Chronic Pancreatitis by cfDNA Next Generation Sequencing from Ductal Fluid Using EUS-Guided FNA: A Prospective Controlled Study. Endoscopy. 57.

Menzel, Michael, Martina Kirchner, Klaus Kluck, et al.. (2024). Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors. The Journal of Pathology Clinical Research. 10(2). e354–e354. 2 indexed citations

Ball, Markus, Klaus Kluck, Michael Menzel, et al.. (2024). Leveraging Off-Target Reads in Panel Sequencing for Homologous Recombination Repair Deficiency Screening in Tumor. Journal of Molecular Diagnostics. 26(6). 479–486.

Christopoulos, Petros, Richard F. Schlenk, Daniel Kazdal, et al.. (2023). Real‐world data for precision cancer medicine—A European perspective. Genes Chromosomes and Cancer. 62(9). 557–563. 9 indexed citations

Ekman, Simon, Florian Guisier, Cheryl Ho, et al.. (2023). 1381P TOGETHER: Pooled real-world datasets of METex14 skipping NSCLC and adjusted comparison of upfront (chemo-)immunotherapy with tepotinib from VISION. Annals of Oncology. 34. S792–S793. 3 indexed citations

Kluck, Klaus, Michael Menzel, Susanne Beck, et al.. (2023). Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis. Cell Death Discovery. 9(1). 126–126. 6 indexed citations

Grünig, Ekkehard, Nicola Benjamin, Hans‐Jürgen Seyfarth, et al.. (2023). Is iron deficiency caused by BMPR2 mutations or dysfunction in pulmonary arterial hypertension patients?. Pulmonary Circulation. 13(2). e12242–e12242. 4 indexed citations

10.

Neumann, Olaf, Markus Ball, Ulrich Lehmann, et al.. (2022). Gene und Pathways: FGFR2‑Translokationen und Fusionsanalytik. PubMed. 43(5). 384–386.

11.

Kazdal, Daniel, Véronique Hofman, Petros Christopoulos, et al.. (2022). Fusion‐positive non‐small cell lung carcinoma: Biological principles, clinical practice, and diagnostic implications. Genes Chromosomes and Cancer. 61(5). 244–260. 38 indexed citations

12.

Rempel, Eugen, Klaus Kluck, Susanne Beck, et al.. (2022). Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD). npj Precision Oncology. 6(1). 36–36. 49 indexed citations

13.

Benesova, Karolina, Margarida Souto‐Carneiro, Florian Eichhorn, et al.. (2022). Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors. Frontiers in Oncology. 12. 1010660–1010660. 12 indexed citations

14.

Kazdal, Daniel, Jelena Cvetković, Martina Kirchner, et al.. (2022). Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine lung carcinoma: a case report. Molecular Case Studies. 8(6). mcs.a006234–mcs.a006234. 9 indexed citations

15.

Thomann, Stefan, Sofia M.E. Weiler, Claudia R. Ball, et al.. (2020). YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis. Cancer Research. 80(24). 5502–5514. 37 indexed citations

16.

Rempel, Eugen, Volker Endris, Michael Allgäuer, et al.. (2020). Immuno‐oncology gene expression profiling of formalin‐fixed and paraffin‐embedded clear cell renal cell carcinoma: Performance comparison of theNanoString nCountertechnology with targetedRNAsequencing. Genes Chromosomes and Cancer. 59(7). 406–416. 9 indexed citations

17.

Bochtler, Tilmann, Volker Endris, Thomas Hielscher, et al.. (2020). Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary. International Journal of Cancer. 146(11). 3053–3064. 10 indexed citations

18.

Kratochwil, Clemens, Frederik L. Giesel, Claus Peter Heußel, et al.. (2019). Patients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair–Associated Genes. Journal of Nuclear Medicine. 61(5). 683–688. 69 indexed citations

19.

Dietz, Steffen, Aviezer Lifshitz, Daniel Kazdal, et al.. (2018). Global DNA methylation reflects spatial heterogeneity and molecular evolution of lung adenocarcinomas. International Journal of Cancer. 144(5). 1061–1072. 24 indexed citations

20.

Leichsenring, Jonas, Anna‐Lena Volckmar, Martina Kirchner, et al.. (2017). Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utility. Genes Chromosomes and Cancer. 57(2). 70–79. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact